Pay to Marwadi

Company Profile

SEQUENT SCIENTIFIC LTD.

NSE : SEQUENTBSE : 512529ISIN CODE : INE807F01027Industry : Pharmaceuticals & DrugsHouse : Sequent
BSE115.30-4.45 (-3.72 % )
PREV CLOSE (Rs.) 119.75
OPEN PRICE (Rs.) 120.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 98296
TODAY'S LOW / HIGH (Rs.)114.90 123.00
52 WK LOW / HIGH (Rs.)66.45 155.45
NSE115.50 -4.3 (-3.59 % )
PREV CLOSE(Rs.) 119.80
OPEN PRICE (Rs.) 119.95
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 115.50 (6855 )
VOLUME 1589443
TODAY'S LOW / HIGH(Rs.) 114.60 122.90
52 WK LOW / HIGH (Rs.)66.25 155.5

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.00
TTM EPS (Rs.) -0.19
P/E Ratio 0.00
Book Value (Rs.) 42.81
Face Value (Rs.) 2
MCap (Rs. in Mn) 28759.68
Price/Earning (TTM) 657.21
Price/Sales (TTM) 16.13
Price/Book (MRQ) 2.69
PAT Margin (%) -2.70
ROCE (%) -0.68
Incorporation Year : 1985

Management Info :

Kamal K Sharma - Chairman Rajaram Narayanan - Managing Director

Registered Office :

Address : 301, ' Dosti Pinnacle',3rd Floor, Plot No. E7,Road No. 22, Wagle Indl. Estate,
Thane,
Maharashtra-400604

Phone : 022 4111 4777

Website : www.sequent.in

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS More
08Feb02-08-2024$Sequent Scientific to sell plot located in Ambernath Industrial Area Sequent Scientific to sell p

Sequent Scientific has executed Deed of assignment on February 08, 2024, for sale of Plot No 7 in the Ambernath Industrial Area, situated at Village Morivali, within the registration Sub District Kalyan, District Thane, at value Rs 7.82 crore (including taxes). The area of the Plot is admeasuring about 7,481 square metres.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. 


Sequent Scientific has executed Deed of assignment on February..
29Dec12-29-2023$ Intimation Intimation
We wish to inform you that the Company has executed Deed of assignment on December 29, 2023 for sale of Plot No. 8 in the Ambernath Industrial Area, situated at Morivali, within the registration Sub District Kalyan, District Thane, admeasuring 8,881 Square meters.
We wish to inform you that the Company has executed Deed of ass..
13Nov11-13-2023$Sequent Scientific informs about transcript of earnings call Sequent Scientific informs a

Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sequent Scientific has informed that it enclosed the Earnings Call Transcript pertaining to the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023. The same is also available on the Company’s website at https://www.sequent.in/pdf/financial/2023- 2024/Sequent%20Transcript_Nov07_2023.pdf.

The above information is a part of company’s filings submitted to BSE.


Pursuant to Regulation 30(6) of the Securities and Exchange Boa..
25Sep09-25-2023$USFDA completes inspection at Sequent Scientific’s Visakhapatnam manufacturing facility USFDA completes inspection a

The United States Food and Drug Administration (USFDA) has completed inspection at Sequent Scientific’s manufacturing facility situated at Visakhapatnam, Andhra Pradesh between September 18, 2023 and September 22, 2023. At the end of the inspection, the company has been issued a Form 483 with one observation. The observation is procedural in nature. The company will respond to the USFDA within the stipulated timeline and work closely with them to address the observation at the earliest.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. 


The United States Food and Drug Administration (USFDA) has comp..
15Sep09-15-2023$Sequent Scientific gets nod to sell API facility in Tarapur Sequent Scientific gets nod

Sequent Scientific has received approval to sell/ transfer its API facility situated at Plot Nos. 136, 137, 138, 139, 140, 141, 150, 151 & W-152, MIDC, Tarapur, Boisar Dist. Thane, Maharashtra, India. The Board of Directors at its meeting held on September 14, 2023 considered and approved the same. 

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. 

Sequent Scientific has received approval to sell/ transfer its..
Financials More
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit45.8-60.8000000000003
Gross Profit 60.9 -97.4600000000003
Operating Profit 92.8818.8199999999997
Net Sales 422.052226.85
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Abbott India (BSE)
 26946.00 (0.74%)
M.Cap ( in Cr)
57258.37
Sanofi India (BSE)
 8118.25 (2.06%)
M.Cap ( in Cr)
18696.83
Dr. Reddy's Lab (BSE)
 6155.15 (1.78%)
M.Cap ( in Cr)
102679.14
Divi's Lab (BSE)
 3436.75 (2.14%)
M.Cap ( in Cr)
91234.91
Glaxosmithkline Phar (BSE)
 1943.10 (3.26%)
M.Cap ( in Cr)
32917.29
Shareholding Pattern More
PROMOTERS 52.79 %
MUTUAL FUNDS/UTI 5.02 %
NON-INSTITUTION 33.86 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes